July 20, 2010

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

.   .   

This RCT did not find that a rituximab-based regimen was superior to standard intravenous cyclophosphamide for severe ANCA-associated vasculitis.

Related Articles:

Acute Kidney Injury, Vasculitis

Comments are closed.